Autovaccines

The use of Autovaccines is particularly relevant in cases where standard treatment methods fail to achieve the desired results or when the infectious agent demonstrates high resistance to antibiotics. The key advantage of this method is its high specificity and ability to stimulate the immune system to develop long-term protection against re-infection.

The process of creating Autovaccines begins with isolating microorganisms from the patient’s biological material, such as blood, sputum, or other bodily fluids. After isolating and identifying the pathogen, it is cultured under laboratory conditions. Then, using specialized methods, a vaccine is created, which is subsequently administered to the patient, stimulating their immune system to develop a targeted immune response.

Autovaccines can be used for the prevention and treatment of a wide range of diseases, including chronic infections, antibiotic-resistant infections, as well as rare and difficult-to-diagnose infectious diseases. Their use not only increases the effectiveness of treatment but also reduces the risk of developing side effects and antibiotic resistance.